Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRF and Fractional CO2 Laser for Postburn Hypertrophic Scars
NCT06664268Phase 1Not yet recruiting
- Sponsor
- Assiut University
- Start
- Nov 2024
- Primary completion
- Nov 2025
- Modality
- Cell Therapies
01
Overview
Phase 1, randomised trial of PRGF-Endoret in Hypertrophic Scar (HS), sponsored by Assiut University. Primary endpoints: Clinical Assessment at 6 months and Ultrasound Assessment at 6 months. Planned start Nov 2024; status: not yet recruiting.
02
Drugs
PRGF-Endoret
03
Conditions
Hypertrophic Scar (HS)
Beyond the preview
Go deeper on NCT06664268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06664268.